Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MyLinh T Duong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell Reports|July 2, 2013
RAP1: protector of telomeres, defender against obesityMyLinh T Duong, Ergün Sahin
Journal of Molecular Biology|June 16, 2007
Changes in apparent free energy of helix-helix dimerization in a biological membrane due to point mutationsMylinh T Duong, Todd M Jaszewski, Karen G Fleming, et al.
Cancer Research|September 9, 2018
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted TherapiesJoseph A Caruso, Mylinh T Duong, Jason P W Carey, et al.
Trends in Biotechnology|September 2, 2014
Hydrophilic carbon clusters as therapeutic, high-capacity antioxidantsErrol L G Samuel, MyLinh T Duong, Brittany R Bitner, et al.
Cancer Research|August 20, 2013
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cellsMylinh T Duong, Said Akli, Sira Macalou, et al.
Plos Genetics|April 6, 2012
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsMyLinh T Duong, Said Akli, Caimiao Wei, et al.
Molecular Therapy Oncolytics|February 12, 2019
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal SwitchesMyLinh T Duong, Matthew R Collinson-Pautz, Eva Morschl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2017
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40Aaron E Foster, Aruna Mahendravada, Nicholas P Shinners, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell Reports|July 2, 2013
RAP1: protector of telomeres, defender against obesityMyLinh T Duong, Ergün Sahin
Journal of Molecular Biology|June 16, 2007
Changes in apparent free energy of helix-helix dimerization in a biological membrane due to point mutationsMylinh T Duong, Todd M Jaszewski, Karen G Fleming, et al.
Cancer Research|September 9, 2018
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted TherapiesJoseph A Caruso, Mylinh T Duong, Jason P W Carey, et al.
Trends in Biotechnology|September 2, 2014
Hydrophilic carbon clusters as therapeutic, high-capacity antioxidantsErrol L G Samuel, MyLinh T Duong, Brittany R Bitner, et al.
Cancer Research|August 20, 2013
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cellsMylinh T Duong, Said Akli, Sira Macalou, et al.
Plos Genetics|April 6, 2012
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsMyLinh T Duong, Said Akli, Caimiao Wei, et al.
Molecular Therapy Oncolytics|February 12, 2019
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal SwitchesMyLinh T Duong, Matthew R Collinson-Pautz, Eva Morschl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2017
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40Aaron E Foster, Aruna Mahendravada, Nicholas P Shinners, et al.
Pageof 1